1. Home
  2. STOK vs OST Comparison

STOK vs OST Comparison

Compare STOK & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • OST
  • Stock Information
  • Founded
  • STOK 2014
  • OST 2010
  • Country
  • STOK United States
  • OST China
  • Employees
  • STOK N/A
  • OST N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • OST Industrial Machinery/Components
  • Sector
  • STOK Health Care
  • OST Technology
  • Exchange
  • STOK Nasdaq
  • OST Nasdaq
  • Market Cap
  • STOK 638.8M
  • OST 601.6M
  • IPO Year
  • STOK 2019
  • OST 2022
  • Fundamental
  • Price
  • STOK $12.03
  • OST $0.13
  • Analyst Decision
  • STOK Strong Buy
  • OST
  • Analyst Count
  • STOK 5
  • OST 0
  • Target Price
  • STOK $24.50
  • OST N/A
  • AVG Volume (30 Days)
  • STOK 541.2K
  • OST 44.3M
  • Earning Date
  • STOK 08-06-2025
  • OST 08-25-2025
  • Dividend Yield
  • STOK N/A
  • OST N/A
  • EPS Growth
  • STOK N/A
  • OST N/A
  • EPS
  • STOK 0.88
  • OST N/A
  • Revenue
  • STOK $190,908,000.00
  • OST $38,333,251.00
  • Revenue This Year
  • STOK $378.84
  • OST N/A
  • Revenue Next Year
  • STOK N/A
  • OST N/A
  • P/E Ratio
  • STOK $13.80
  • OST N/A
  • Revenue Growth
  • STOK 2333.81
  • OST 0.34
  • 52 Week Low
  • STOK $5.35
  • OST $0.12
  • 52 Week High
  • STOK $16.15
  • OST $9.40
  • Technical
  • Relative Strength Index (RSI)
  • STOK 67.00
  • OST 24.67
  • Support Level
  • STOK $11.19
  • OST $0.13
  • Resistance Level
  • STOK $12.00
  • OST $0.22
  • Average True Range (ATR)
  • STOK 0.54
  • OST 0.88
  • MACD
  • STOK -0.04
  • OST -0.63
  • Stochastic Oscillator
  • STOK 75.30
  • OST 0.11

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About OST Ostin Technology Group Co. Ltd.

Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.

Share on Social Networks: